Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (11-20 of 254) with videos related to

Pageof 26
Sort By:
Frontiers in Genetics|August 23, 2016
Comparing Analytic Methods for Longitudinal GWAS and a Case-Study Evaluating Chemotherapy Course Length in Pediatric AML. A Report from the Children's Oncology GroupMarijana Vujkovic, Richard Aplenc, Todd A Alonzo, et al.
Pediatric Blood & Cancer|February 27, 2024
Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorshipJenny Ruiz, Rebecca K Kelly, Richard Aplenc, et al.
Pediatric Blood & Cancer|June 10, 2010
Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort studyBrian T Fisher, Theoklis E Zaoutis, Kateri H Leckerman, et al.
The Pediatric Infectious Disease Journal|October 28, 2009
Cefepime and mortality in pediatric acute myelogenous leukemia: a retrospective cohort studyBrian T Fisher, Richard Aplenc, Russell Localio, et al.
Journal of the Pediatric Infectious Diseases Society|October 4, 2025
Fluoroquinolone Susceptibility and Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients With Hematologic MalignancyEleana Vasileiadi, Caitlin W Elgarten, Kelly D Getz, et al.
The Journal of Pediatrics|March 13, 2013
Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancerPeter de Blank, Theoklis Zaoutis, Brian Fisher, et al.
Biostatistics (Oxford, England)|January 17, 2024
Bayesian semiparametric model for sequential treatment decisions with informative timingArman Oganisian, Kelly D Getz, Todd A Alonzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031Soheil Meshinchi, Stephen P Hunger, Richard Aplenc, et al.
Pediatric Blood & Cancer|February 24, 2015
The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology GroupElizabeth G Salazar, M Brooke Bernhardt, Yimei Li, et al.
Cancer Research|August 3, 2002
Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemiaJenny M Kim, Junjie Fang, Susan Rheingold, et al.
Pageof 26

Showing results (11-20 of 254) with videos related to

Sort By:
Pageof 26
Frontiers in Genetics|August 23, 2016
Comparing Analytic Methods for Longitudinal GWAS and a Case-Study Evaluating Chemotherapy Course Length in Pediatric AML. A Report from the Children's Oncology GroupMarijana Vujkovic, Richard Aplenc, Todd A Alonzo, et al.
Pediatric Blood & Cancer|February 27, 2024
Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorshipJenny Ruiz, Rebecca K Kelly, Richard Aplenc, et al.
Pediatric Blood & Cancer|June 10, 2010
Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort studyBrian T Fisher, Theoklis E Zaoutis, Kateri H Leckerman, et al.
The Pediatric Infectious Disease Journal|October 28, 2009
Cefepime and mortality in pediatric acute myelogenous leukemia: a retrospective cohort studyBrian T Fisher, Richard Aplenc, Russell Localio, et al.
Journal of the Pediatric Infectious Diseases Society|October 4, 2025
Fluoroquinolone Susceptibility and Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients With Hematologic MalignancyEleana Vasileiadi, Caitlin W Elgarten, Kelly D Getz, et al.
The Journal of Pediatrics|March 13, 2013
Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancerPeter de Blank, Theoklis Zaoutis, Brian Fisher, et al.
Biostatistics (Oxford, England)|January 17, 2024
Bayesian semiparametric model for sequential treatment decisions with informative timingArman Oganisian, Kelly D Getz, Todd A Alonzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031Soheil Meshinchi, Stephen P Hunger, Richard Aplenc, et al.
Pediatric Blood & Cancer|February 24, 2015
The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology GroupElizabeth G Salazar, M Brooke Bernhardt, Yimei Li, et al.
Cancer Research|August 3, 2002
Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemiaJenny M Kim, Junjie Fang, Susan Rheingold, et al.
Pageof 26